| 10001 | AHSP/CA2 ratio | GCST90313215 | 1.72e-03 |
| 10002 | Anxiety disorders (more control exclusions) | FING00000098 | 1.72e-03 |
| 10003 | Treatment speciality of consultant (recoded) - Urology | Summary Administration | UKBB00000838 | 1.72e-03 |
| 10004 | Clinical anxiety and depression (confirmatory factor analysis Factor 3) | GCST90309338 | 1.71e-03 |
| 10005 | Lysoalkylphosphatidylcholine (O-20:0) levels | GCST90024193 | 1.70e-03 |
| 10006 | Papulosquamous disorders | FING00001144 | 1.70e-03 |
| 10007 | Impacted cerumen (PheCode 380.4) | GCST90475901 | 1.69e-03 |
| 10008 | Disorders of choroid and retina | FING00000438 | 1.68e-03 |
| 10009 | Cervical disc disorders | FING00000265 | 1.67e-03 |
| 10010 | PDLIM7 levels | GCST90470198 | 1.67e-03 |
| 10011 | Hyphaema and other vascular disorders of iris and ciliary body | FING00000647 | 1.67e-03 |
| 10012 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T23 | ECGU000023 | 1.67e-03 |
| 10013 | rfMRI connectivity (ICA100 edge 605) | GCST90005458 | 1.67e-03 |
| 10014 | RNASE1 levels | GCST90470476 | 1.67e-03 |
| 10015 | Left ventricular end diastole inferior wall thickness | GCST90278515 | 1.67e-03 |
| 10016 | ITGB1BP2/LAT2 ratio | GCST90315212 | 1.66e-03 |
| 10017 | Chalazion | FING00000267 | 1.66e-03 |
| 10018 | Working memory | GCST90503116 | 1.66e-03 |
| 10019 | FAS levels | GCST90090701 | 1.66e-03 |
| 10020 | Left-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302658 | 1.65e-03 |
| 10021 | COL2A1 levels | GCST90468816 | 1.64e-03 |
| 10022 | IDP T1 FAST ROIs R cerebellum X | GCST90002589 | 1.64e-03 |
| 10023 | Physical activity (Total log acceleration 12am-2am) | GCST90061409 | 1.63e-03 |
| 10024 | Free androgen index | GCST90239824 | 1.62e-03 |
| 10025 | Plasma X-25279 levels in chronic kidney disease | GCST90266835 | 1.62e-03 |
| 10026 | TGFBI levels | GCST90470845 | 1.62e-03 |
| 10027 | LAT/SPARC ratio | GCST90315288 | 1.62e-03 |
| 10028 | Volume of left whole amygdala | GCST90474988 | 1.61e-03 |
| 10029 | aparc-Desikan rh area lingual | GCST90003119 | 1.61e-03 |
| 10030 | Systolic blood pressure | GCST90018752 | 1.61e-03 |
| 10031 | wg rh intensity-contrast lingual | GCST90003839 | 1.61e-03 |
| 10032 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T426 | ECGA000426 | 1.60e-03 |
| 10033 | Pre-existing hypertension complicating pregnancy, childbirth and the puerperium | FING00001203 | 1.60e-03 |
| 10034 | VTI1A levels | GCST90471060 | 1.59e-03 |
| 10035 | DTI TBSS L2 Sagittal stratum L | GCST90384507 | 1.59e-03 |
| 10036 | T1 FreeSurfer pial rh pericalcarine area | GCST90385842 | 1.59e-03 |
| 10037 | AmygNuclei lh volume Cortical-nucleus | GCST90002654 | 1.59e-03 |
| 10038 | NFE2 levels | GCST90470035 | 1.58e-03 |
| 10039 | Weight (mean, inv-normal transformed) | GCST90476463 | 1.58e-03 |
| 10040 | Free testosterone levels | GCST90239826 | 1.58e-03 |
| 10041 | Takes medication for Glaucoma? | GCST90475384 | 1.57e-03 |
| 10042 | Mean platelet volume at delivery | GCST90302232 | 1.57e-03 |
| 10043 | Maximum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000428 | 1.57e-03 |
| 10044 | Creatinine levels (UKB data field 23478) | GCST90269575 | 1.57e-03 |
| 10045 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T425 | ECGA000425 | 1.57e-03 |
| 10046 | Frequency of travelling from home to job workplace | Employment | UKBB00000269 | 1.56e-03 |
| 10047 | RNF43 levels | GCST90470486 | 1.56e-03 |
| 10048 | BACH1/NFATC1 ratio | GCST90313444 | 1.56e-03 |
| 10049 | Other and unspecified polyneuropathies, also in other diseases | FING00000948 | 1.56e-03 |
| 10050 | Fractured bone site(s) - Other bones | Medical conditions | UKBB00000256 | 1.56e-03 |
| 10051 | Internal derangement of knee (PheCode 835) | GCST90476282 | 1.56e-03 |
| 10052 | DTI TBSS L1 Superior longitudinal fasciculus L | GCST90384469 | 1.56e-03 |
| 10053 | PHYKPL levels | GCST90470228 | 1.56e-03 |
| 10054 | Peptic ulcer (excl. esophageal) | digestive | UKBB00000639 | 1.56e-03 |
| 10055 | CDHR2/MME ratio | GCST90313963 | 1.56e-03 |
| 10056 | SEPTIN8 levels | GCST90470578 | 1.56e-03 |
| 10057 | LCN2/S100A12 ratio | GCST90315309 | 1.55e-03 |
| 10058 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T433 | ECGU000433 | 1.55e-03 |
| 10059 | Illnesses of mother - High blood pressure | Family history | UKBB00000348 | 1.55e-03 |
| 10060 | Breast cancer | neoplasms | UKBB00000109 | 1.55e-03 |
| 10061 | B2M levels | GCST90468409 | 1.55e-03 |
| 10062 | LSIL lesion of the cervix uteri | FING00000732 | 1.55e-03 |
| 10063 | aparc-DKTatlas rh area parstriangularis | GCST90003283 | 1.54e-03 |
| 10064 | Ulcerative rectosigmoiditis | FING00001394 | 1.54e-03 |
| 10065 | SHBG levels | GCST90503315 | 1.54e-03 |
| 10066 | aparc-a2009s rh volume S-orbital-H-Shaped | GCST90003062 | 1.54e-03 |
| 10067 | TPK1 levels | GCST90470943 | 1.53e-03 |
| 10068 | ThalamNuclei lh volume MDl | GCST90002724 | 1.53e-03 |
| 10069 | Osteopathies and chondropathies | FING00000913 | 1.52e-03 |
| 10070 | T1 FreeSurfer DK lh precentral thickness | GCST90385645 | 1.52e-03 |
| 10071 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T30 | ECGU000030 | 1.52e-03 |
| 10072 | CREG1/GUSB ratio | GCST90314249 | 1.51e-03 |
| 10073 | Left-hemisphere control network to right-hemisphere visual network white-matter structural connectivity | GCST90302745 | 1.50e-03 |
| 10074 | EDAR/SDC4 ratio | GCST90314585 | 1.49e-03 |
| 10075 | Illnesses of siblings - Diabetes | Family history | UKBB00000350 | 1.49e-03 |
| 10076 | CD2AP/USP8 ratio | GCST90313784 | 1.49e-03 |
| 10077 | ATG4A levels | GCST90468384 | 1.49e-03 |
| 10078 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T64 | ECGA000064 | 1.49e-03 |
| 10079 | Forced expiratory volume in 1-second (FEV1), predicted percentage | Spirometry | UKBB00000253 | 1.49e-03 |
| 10080 | AGXT levels | GCST90468258 | 1.49e-03 |
| 10081 | Volume of right whole amygdala | GCST90475054 | 1.48e-03 |
| 10082 | PCBD1 levels | GCST90470166 | 1.48e-03 |
| 10083 | Intestinal infectious diseases | FING00000689 | 1.47e-03 |
| 10084 | Blood cell traits latent factor 7 (white cell) | GCST90559249 | 1.47e-03 |
| 10085 | Edema (PheCode 782.3) | GCST90476272 | 1.46e-03 |
| 10086 | BMP6/SPINT2 ratio | GCST90313529 | 1.46e-03 |
| 10087 | Pelvic inlet width | GCST90448910 | 1.46e-03 |
| 10088 | ANGPT1/PDGFA ratio | GCST90313266 | 1.46e-03 |
| 10089 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T460 | ECGA000460 | 1.46e-03 |
| 10090 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T17 | ECGU000017 | 1.45e-03 |
| 10091 | IDP dMRI TBSS MO Cerebral peduncle R | GCST90003966 | 1.45e-03 |
| 10092 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T266 | ECGU000266 | 1.45e-03 |
| 10093 | LTBR levels | GCST90243176 | 1.45e-03 |
| 10094 | DNMBP/WWP2 ratio | GCST90314522 | 1.45e-03 |
| 10095 | CXCL17/SFTPA2 ratio | GCST90314341 | 1.45e-03 |
| 10096 | T1 FreeSurfer aseg Right-Lateral-Ventricle | GCST90384157 | 1.44e-03 |
| 10097 | TNFRSF1A levels | GCST90012015 | 1.44e-03 |
| 10098 | Retention of urine | FING00001257 | 1.44e-03 |
| 10099 | Treatment/medication code - perindopril | Medications | UKBB00000854 | 1.43e-03 |
| 10100 | Nontoxic multinodular goiter | endocrine/metabolic | UKBB00000528 | 1.43e-03 |
| 10101 | TSTA3 levels | GCST90421854 | 1.43e-03 |
| 10102 | FYB1/PPP1R12A ratio | GCST90314913 | 1.43e-03 |
| 10103 | Migraine with aura | FING00000819 | 1.43e-03 |
| 10104 | Asthma, unspecified (mode) | FING00000120 | 1.43e-03 |
| 10105 | DECR1/FXN ratio | GCST90314446 | 1.43e-03 |
| 10106 | Male-pattern baldness | GCST006661 | 1.43e-03 |
| 10107 | MMP9/PLAUR ratio | GCST90315470 | 1.42e-03 |
| 10108 | Gestational [pregnancy-induced] oedema and proteinuria without hypertension | FING00000572 | 1.42e-03 |
| 10109 | Total cerebellar volume (excluding Crus I vermis) | GCST90020190 | 1.42e-03 |
| 10110 | IL15/NCR1 ratio | GCST90315150 | 1.42e-03 |
| 10111 | Hemorrhagic fever with renal syndrome | GCST90454190 | 1.42e-03 |
| 10112 | SLMAP levels | GCST90470673 | 1.42e-03 |
| 10113 | Malignant neoplasm of breast | Malignant neoplasm of breast | UKBB00000424 | 1.42e-03 |
| 10114 | Nephritis and nephropathy in diseases classified elsewhere (PheCode 580.31) | GCST90476116 | 1.41e-03 |
| 10115 | Volume of right accessory basal nucleus | GCST90474907 | 1.41e-03 |
| 10116 | Macular degeneration (senile) of retina NOS (PheCode 362.29) | GCST90475857 | 1.41e-03 |
| 10117 | AHCY levels | GCST90468259 | 1.41e-03 |
| 10118 | FABP1/SULT2A1 ratio | GCST90314755 | 1.41e-03 |
| 10119 | Blood cell traits latent factor 6 (red cell (and basophil)) | GCST90559248 | 1.41e-03 |
| 10120 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T3 | ECGU000003 | 1.41e-03 |
| 10121 | total creatine kinase (minimum, inv-norm transformed) | GCST90476416 | 1.40e-03 |
| 10122 | Chronic bronchitis | GCST90018604 | 1.40e-03 |
| 10123 | Plasma ascorbic acid 2-sulfate levels in chronic kidney disease | GCST90264832 | 1.40e-03 |
| 10124 | IDP dMRI TBSS FA Cingulum cingulate gyrus R | GCST90003911 | 1.40e-03 |
| 10125 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T454 | ECGA000454 | 1.40e-03 |
| 10126 | MANF/TXNDC5 ratio | GCST90315370 | 1.40e-03 |
| 10127 | Single spontaneous delivery | FING00001307 | 1.40e-03 |
| 10128 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | GCST90320928 | 1.40e-03 |
| 10129 | CD20 on IgD- CD38- B cell | GCST90001755 | 1.39e-03 |
| 10130 | GOLGA3 levels | GCST90469375 | 1.39e-03 |
| 10131 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T452 | ECGA000452 | 1.39e-03 |
| 10132 | Isolated hypothyroxinemia in pregnancy | GCST90435198 | 1.39e-03 |
| 10133 | ESM1 levels | GCST90012068 | 1.38e-03 |
| 10134 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T445 | ECGA000445 | 1.38e-03 |
| 10135 | Dorsalgia | FING00000472 | 1.38e-03 |
| 10136 | CD84/TREML2 ratio | GCST90313919 | 1.38e-03 |
| 10137 | Clonal hematopoiesis (large clone) | GCST90102621 | 1.38e-03 |
| 10138 | CNTN4 levels | GCST90240786 | 1.38e-03 |
| 10139 | Birth size (multivariate analysis) | GCST90624101 | 1.38e-03 |
| 10140 | CKMB levels | GCST90475221 | 1.37e-03 |
| 10141 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T271 | ECGU000271 | 1.37e-03 |
| 10142 | wg lh intensity-contrast paracentral | GCST90003808 | 1.37e-03 |
| 10143 | Hypo-osmolality and hyponatraemia | FING00000648 | 1.37e-03 |
| 10144 | TNFAIP2 levels | GCST90470896 | 1.36e-03 |
| 10145 | IDP dMRI ProbtrackX L1 ptr l | GCST90004265 | 1.35e-03 |
| 10146 | IDP dMRI TBSS ICVF Fornix cres+Stria terminalis R | GCST90004365 | 1.35e-03 |
| 10147 | DUSP29 levels | GCST90469052 | 1.35e-03 |
| 10148 | KIR2DL3 levels | GCST90469685 | 1.35e-03 |
| 10149 | Anterior diffusion tensor imaging along the perivascular space index | GCST90455543 | 1.35e-03 |
| 10150 | SMTN levels | GCST90470689 | 1.35e-03 |
| 10151 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T7 | ECGU000007 | 1.34e-03 |
| 10152 | Waist-to-hip ratio adjusted for BMI | GCST012230 | 1.34e-03 |
| 10153 | SLC5A8 levels | GCST90242850 | 1.34e-03 |
| 10154 | SWAP70 levels | GCST90242931 | 1.34e-03 |
| 10155 | Reimbursement for rheumatic diseases | FING00001247 | 1.34e-03 |
| 10156 | Right-hemisphere somatomotor network to hippocampus white-matter structural connectivity | GCST90302798 | 1.32e-03 |
| 10157 | Vitamin and mineral supplements - Multivitamins +/- minerals | Medication | UKBB00000900 | 1.32e-03 |
| 10158 | Prospective memory result | Prospective memory | UKBB00000713 | 1.32e-03 |
| 10159 | UGDH levels | GCST90471006 | 1.32e-03 |
| 10160 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T483 | ECGA000483 | 1.32e-03 |
| 10161 | BA-exvivo lh area V1 | GCST90003216 | 1.32e-03 |
| 10162 | Myocardial fractal dimension (slice 5) | GCST90000291 | 1.32e-03 |
| 10163 | FUT8/TNFSF14 ratio | GCST90314895 | 1.31e-03 |
| 10164 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T427 | ECGA000427 | 1.31e-03 |
| 10165 | DTI autoptx L2 str r tract | GCST90385190 | 1.31e-03 |
| 10166 | KRT19 levels | GCST90469717 | 1.31e-03 |
| 10167 | TCN1 levels | GCST90470819 | 1.31e-03 |
| 10168 | MMP3 levels | GCST90012027 | 1.31e-03 |
| 10169 | Episodal and paroxysmal disorders | FING00000514 | 1.30e-03 |
| 10170 | Glaucoma | FING00000577 | 1.30e-03 |
| 10171 | IGFBP6/SMOC2 ratio | GCST90315138 | 1.30e-03 |
| 10172 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T424 | ECGA000424 | 1.29e-03 |
| 10173 | Barrett's esophagus or Esophageal adenocarcinoma | GCST003740 | 1.29e-03 |
| 10174 | PYDC1 levels | GCST90470397 | 1.29e-03 |
| 10175 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T55 | ECGU000055 | 1.28e-03 |
| 10176 | IDP dMRI ProbtrackX L2 cgc r | GCST90004278 | 1.28e-03 |
| 10177 | IDP dMRI TBSS MD Retrolenticular part of internal capsule R | GCST90004047 | 1.28e-03 |
| 10178 | Psoas tendinitis | FING00001221 | 1.28e-03 |
| 10179 | Chronic sinusitis (PheCode 475) | GCST90476020 | 1.28e-03 |
| 10180 | Campesterol levels | GCST90199725 | 1.28e-03 |
| 10181 | Medication use (immunosuppressants) | GCST90018771 | 1.28e-03 |
| 10182 | Malignant neoplasm, excluding all cancers (controls excluding all cancers) | FING00000780 | 1.28e-03 |
| 10183 | Eosinophil percentage of white cells | GCST90002382 | 1.28e-03 |
| 10184 | Usual side of head for mobile phone use - Right | Electronic device use | UKBB00000890 | 1.27e-03 |
| 10185 | Vanillylmandelate (VMA) levels | GCST90200309 | 1.27e-03 |
| 10186 | aparc-a2009s rh area G-occipital-sup | GCST90003390 | 1.27e-03 |
| 10187 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91) | GCST90320654 | 1.27e-03 |
| 10188 | DBNL/HSPA1A ratio | GCST90314418 | 1.27e-03 |
| 10189 | Principal component-derived dietary pattern 36 | GCST90133041 | 1.27e-03 |
| 10190 | Smoking/smokers in household | Smoking | UKBB00000783 | 1.27e-03 |
| 10191 | Never eat eggs, dairy, wheat, sugar - I eat all of the above | Diet | UKBB00000500 | 1.27e-03 |
| 10192 | Asthma with exacerbation (PheCode 495.2) | GCST90476025 | 1.26e-03 |
| 10193 | Ovarian cyst | FING00001132 | 1.26e-03 |
| 10194 | N-acetyl-2-aminoadipate levels | GCST90200268 | 1.26e-03 |
| 10195 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T496 | ECGU000496 | 1.26e-03 |
| 10196 | CLEC1B/EGF ratio | GCST90314089 | 1.26e-03 |
| 10197 | Atrophic disorders of skin | FING00000129 | 1.26e-03 |
| 10198 | FCER2 levels | GCST90469199 | 1.26e-03 |
| 10199 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T49 | ECGU000049 | 1.25e-03 |
| 10200 | DSC2/EFEMP1 ratio | GCST90314555 | 1.25e-03 |
| 10201 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T69 | ECGA000069 | 1.25e-03 |
| 10202 | wg rh intensity-contrast inferiorparietal | GCST90003834 | 1.25e-03 |
| 10203 | SYAP1 levels | GCST90470792 | 1.24e-03 |
| 10204 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T117 | ECGU000117 | 1.24e-03 |
| 10205 | Bariatric surgery (PheCode 539) | GCST90476055 | 1.24e-03 |
| 10206 | Volume of right lateral nucleus | GCST90475039 | 1.23e-03 |
| 10207 | Cereal intake | Diet | UKBB00000121 | 1.23e-03 |
| 10208 | HTRA2/TRIAP1 ratio | GCST90315099 | 1.23e-03 |
| 10209 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T21 | ECGU000021 | 1.23e-03 |
| 10210 | IDP T1 FAST ROIs L cerebellum VIIIb | GCST90002581 | 1.23e-03 |
| 10211 | Non-ischemic cardiomyopathy | FING00000873 | 1.22e-03 |
| 10212 | SERPINE1/USP8 ratio | GCST90315835 | 1.22e-03 |
| 10213 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108) | GCST90320671 | 1.22e-03 |
| 10214 | Pain type(s) experienced in last month - None of the above | Pain | UKBB00000631 | 1.21e-03 |
| 10215 | T1 CAT volume Vermis VIIIa | GCST90384128 | 1.21e-03 |
| 10216 | Insomnia complaints | GCST006487 | 1.21e-03 |
| 10217 | RNASE6 levels | GCST90470479 | 1.21e-03 |
| 10218 | REST UKBBICA NODEamps25 0016 | GCST90385499 | 1.20e-03 |
| 10219 | Hypertensive heart disease (PheCode 401.21) | GCST90475925 | 1.20e-03 |
| 10220 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T39 | ECGU000039 | 1.20e-03 |
| 10221 | wg rh intensity-contrast cuneus | GCST90003831 | 1.20e-03 |
| 10222 | Mean volume of bilateral amygdala | GCST90474994 | 1.19e-03 |
| 10223 | CD48/SLAMF7 ratio | GCST90313842 | 1.19e-03 |
| 10224 | Fasting glucose | GCST90278628 | 1.19e-03 |
| 10225 | IL12B levels | GCST90469549 | 1.19e-03 |
| 10226 | Other infective otitis externa | FING00001060 | 1.18e-03 |
| 10227 | DTI TBSS MO Middle cerebellar peduncle | GCST90384620 | 1.18e-03 |
| 10228 | Rheumatoid arthritis | GCST90018690 | 1.18e-03 |
| 10229 | Waist-hip ratio | GCST90278649 | 1.18e-03 |
| 10230 | Autorefraction - 3mm strong meridian angle (left) | Eyesight | UKBB00000067 | 1.17e-03 |
| 10231 | CLEC1B/DKK1 ratio | GCST90314088 | 1.17e-03 |
| 10232 | IDP T1 FIRST right caudate volume | GCST90002439 | 1.17e-03 |
| 10233 | DTI TBSS L1 Body of corpus callosum | GCST90384431 | 1.17e-03 |
| 10234 | Diastolic blood pressure (UKB data field 4079) | GCST90468163 | 1.17e-03 |
| 10235 | Menorrhagia | FING00000808 | 1.17e-03 |
| 10236 | Bone density Z-score | GCST90278621 | 1.15e-03 |
| 10237 | TNFRSF13C/TNFSF13B ratio | GCST90315934 | 1.15e-03 |
| 10238 | TIA1/USP8 ratio | GCST90315920 | 1.15e-03 |
| 10239 | Rheumatoid arthritis | GCST90132223 | 1.15e-03 |
| 10240 | Benign neoplasm: Rectum, anus and anal canal | FING00000197 | 1.15e-03 |
| 10241 | RBPMS2 levels | GCST90470441 | 1.15e-03 |
| 10242 | Cardiorespiratory fitness slope | GCST90093319 | 1.14e-03 |
| 10243 | Cognitive performance | GCST006572 | 1.14e-03 |
| 10244 | DNA methylation-estimated granulocyte proportions | GCST90014287 | 1.14e-03 |
| 10245 | Completion of the aide-memoire | GCST90012793 | 1.13e-03 |
| 10246 | Juvenile arthritis (FINNGEN) | FING00000704 | 1.13e-03 |
| 10247 | IDP dMRI ProbtrackX L2 ilf l | GCST90004287 | 1.13e-03 |
| 10248 | CCL13/CCL2 ratio | GCST90313675 | 1.13e-03 |
| 10249 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T207 | ECGA000207 | 1.13e-03 |
| 10250 | ENO2/ITGB1BP2 ratio | GCST90314661 | 1.13e-03 |
| 10251 | Sedentary behavior at work | GCST90104345 | 1.12e-03 |
| 10252 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T127 | ECGA000127 | 1.12e-03 |
| 10253 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T265 | ECGU000265 | 1.12e-03 |
| 10254 | Time spent driving | Physical activity | UKBB00000818 | 1.11e-03 |
| 10255 | HLA-A levels | GCST90469457 | 1.11e-03 |
| 10256 | Prescriptions - thyroid hormone | hormone | UKBB00000705 | 1.11e-03 |
| 10257 | Prescriptions - levothyroxine | thyroid hormone | UKBB00000687 | 1.11e-03 |
| 10258 | VEGFA levels | GCST90011995 | 1.11e-03 |
| 10259 | PLEKHO1 levels | GCST90470256 | 1.11e-03 |
| 10260 | Urine adenosine levels in chronic kidney disease | GCST90264757 | 1.11e-03 |
| 10261 | NPHS1 levels | GCST90470070 | 1.10e-03 |
| 10262 | DTI TBSS L1 External capsule L | GCST90384461 | 1.10e-03 |
| 10263 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T74 | ECGA000074 | 1.10e-03 |
| 10264 | ARHGEF12 levels | GCST90468358 | 1.10e-03 |
| 10265 | CCL17/GRK5 ratio | GCST90313687 | 1.09e-03 |
| 10266 | Left-hemisphere visual network to right-hemisphere visual network white-matter structural connectivity | GCST90302655 | 1.09e-03 |
| 10267 | Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57) | GCST90668735 | 1.09e-03 |
| 10268 | Spondylosis without myelopathy (PheCode 721.1) | GCST90476236 | 1.08e-03 |
| 10269 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T444 | ECGA000444 | 1.08e-03 |
| 10270 | CST6/NECTIN4 ratio | GCST90314303 | 1.08e-03 |
| 10271 | aseg rh intensity Cerebellum-Cortex | GCST90003781 | 1.08e-03 |
| 10272 | X-08402 levels | GCST90243538 | 1.08e-03 |
| 10273 | Elevated prostate specific antigen [PSA] (PheCode 796) | GCST90476277 | 1.08e-03 |
| 10274 | Left-hemisphere visual network to caudate white-matter structural connectivity | GCST90302663 | 1.08e-03 |
| 10275 | Suicide or other Intentional self-harm | FING00001345 | 1.08e-03 |
| 10276 | IDP dMRI ProbtrackX MD ilf l | GCST90004233 | 1.07e-03 |
| 10277 | Breast size | GCST006655 | 1.07e-03 |
| 10278 | Lichen sclerosus et atrophicus | FING00000723 | 1.07e-03 |
| 10279 | Idiopathic pulmonary fibrosis | FING00000659 | 1.07e-03 |
| 10280 | BIN2/FYB1 ratio | GCST90313505 | 1.07e-03 |
| 10281 | red blood cell count (RBC, maximum, inv-norm transformed) | GCST90476343 | 1.07e-03 |
| 10282 | Panic attacks | Mental distress | UKBB00000634 | 1.07e-03 |
| 10283 | Glaucoma | Glaucoma | UKBB00000286 | 1.07e-03 |
| 10284 | Feeling guilty | GCST006945 | 1.06e-03 |
| 10285 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T451 | ECGA000451 | 1.06e-03 |
| 10286 | Calcific tendinitis of shoulder | FING00000235 | 1.06e-03 |
| 10287 | TAB2 levels | GCST90470796 | 1.06e-03 |
| 10288 | Medication use (calcium channel blockers) | GCST90018767 | 1.06e-03 |
| 10289 | Bone density T-score | GCST90278620 | 1.06e-03 |
| 10290 | Triglyceride to HDL cholesterol ratio | GCST90295953 | 1.05e-03 |
| 10291 | ENO2/TXNDC5 ratio | GCST90314671 | 1.05e-03 |
| 10292 | Glaucoma | sense organs | UKBB00000287 | 1.05e-03 |
| 10293 | MAP2 levels | GCST90469853 | 1.05e-03 |
| 10294 | Disorders of sclera, cornea, iris and ciliary body | FING00000458 | 1.05e-03 |
| 10295 | Operation code - squint correction | Operations | UKBB00000566 | 1.04e-03 |
| 10296 | HNRNPK/VASH1 ratio | GCST90315071 | 1.04e-03 |
| 10297 | ADAMTS15/SULT2A1 ratio | GCST90313171 | 1.04e-03 |
| 10298 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T477 | ECGA000477 | 1.04e-03 |
| 10299 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T264 | ECGU000264 | 1.04e-03 |
| 10300 | CLEC4D/TGFA ratio | GCST90314117 | 1.03e-03 |
| 10301 | LAIR2 levels | GCST90469729 | 1.03e-03 |
| 10302 | Osteochondrodysplasia with defects of growth of tubular bones and spine | FING00000910 | 1.03e-03 |
| 10303 | Percentage of M9 (GP18) | GCST90668462 | 1.03e-03 |
| 10304 | Rheumatoid arthritis | GCST90132224 | 1.03e-03 |
| 10305 | Atrial fibrillation and flutter | FING00000126 | 1.03e-03 |
| 10306 | Right-hemisphere dorsal attention network to hippocampus white-matter structural connectivity | GCST90302810 | 1.03e-03 |
| 10307 | SCLY levels | GCST90470546 | 1.02e-03 |
| 10308 | Benign neoplasm of colon, rectum, anus and anal canal | FING00000155 | 1.02e-03 |
| 10309 | Alkylphosphatidylcholine (O-16:0/16:0) levels | GCST90024913 | 1.02e-03 |
| 10310 | aparc-pial lh area pericalcarine | GCST90003161 | 1.02e-03 |
| 10311 | DTI TBSS L1 Fornix | GCST90384433 | 1.02e-03 |
| 10312 | wg lh intensity-contrast inferiortemporal | GCST90003800 | 1.02e-03 |
| 10313 | CCL20 levels | GCST90012077 | 1.02e-03 |
| 10314 | CCL4 levels | GCST90274770 | 1.02e-03 |
| 10315 | Weight, inverse-rank normalized | FING00001447 | 1.02e-03 |
| 10316 | T1 FreeSurfer a2009s rh S temporal sup volume | GCST90385110 | 1.02e-03 |
| 10317 | DTI TBSS L3 Posterior thalamic radiation L | GCST90384553 | 1.02e-03 |
| 10318 | T1 FreeSurfer BA lh BA2 exvivo volume | GCST90385534 | 1.01e-03 |
| 10319 | CES2 levels | GCST90468719 | 1.01e-03 |
| 10320 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T423 | ECGU000423 | 1.01e-03 |
| 10321 | ART3/GPC1 ratio | GCST90313361 | 1.01e-03 |
| 10322 | Tachycardia NOS (PheCode 427.7) | GCST90475979 | 1.01e-03 |
| 10323 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T6 | ECGU000006 | 1.00e-03 |
| 10324 | Nontoxic multinodular goitre | FING00000888 | 1.00e-03 |
| 10325 | Eosinophill percentage (UKB data field 30210) | GCST90468069 | 1.00e-03 |
| 10326 | Cereal consumption (bowls per week) (UKB data field 1458) | GCST90132982 | 9.99e-04 |
| 10327 | FCER2/TREML2 ratio | GCST90314792 | 9.99e-04 |
| 10328 | ADAMTS15/CLMP ratio | GCST90313170 | 9.97e-04 |
| 10329 | IDP dMRI ProbtrackX ISOVF ilf r | GCST90004540 | 9.95e-04 |
| 10330 | Temporomandibular joint disorders | FING00001354 | 9.93e-04 |
| 10331 | X-16087 levels | GCST90200537 | 9.92e-04 |
| 10332 | Glaucoma (primary open-angle) | GCST90399725 | 9.90e-04 |
| 10333 | GIPC2 levels | GCST90469347 | 9.89e-04 |
| 10334 | NT5C3A/SCRN1 ratio | GCST90315569 | 9.89e-04 |
| 10335 | Waist-hip index | GCST012228 | 9.89e-04 |
| 10336 | rfMRI amplitudes (ICA100 node 12) | GCST90004600 | 9.87e-04 |
| 10337 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T33 | ECGU000033 | 9.86e-04 |
| 10338 | ACY3 levels | GCST90468213 | 9.85e-04 |
| 10339 | Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers) | FING00000756 | 9.84e-04 |
| 10340 | Orotidine levels | GCST90200681 | 9.83e-04 |
| 10341 | Main speciality of consultant (recoded) - Anaesthetics | Summary Administration | UKBB00000413 | 9.82e-04 |
| 10342 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T208 | ECGA000208 | 9.81e-04 |
| 10343 | Acute pancreatitis | FING00000027 | 9.80e-04 |
| 10344 | Chronic sputum production | GCST90269902 | 9.79e-04 |
| 10345 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T142 | ECGU000142 | 9.78e-04 |
| 10346 | Atrial flutter (PheCode 427.22) | GCST90475973 | 9.76e-04 |
| 10347 | Diastolic blood pressure, automated reading | Blood pressure | UKBB00000173 | 9.69e-04 |
| 10348 | Irregular menses | FING00000701 | 9.69e-04 |
| 10349 | Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000176 | 9.69e-04 |
| 10350 | Succinoyltaurine levels | GCST90200235 | 9.67e-04 |
| 10351 | OSM/TGFA ratio | GCST90315590 | 9.65e-04 |
| 10352 | ICD10 C50.9: Malignant neoplasm of breast of unspecified site | GCST90043889 | 9.62e-04 |
| 10353 | Mineral and other dietary supplements - None of the above | Medication | UKBB00000474 | 9.55e-04 |
| 10354 | EPHB6 levels | GCST90469133 | 9.53e-04 |
| 10355 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T268 | ECGU000268 | 9.49e-04 |
| 10356 | aparc-Desikan rh volume parsopercularis | GCST90002818 | 9.49e-04 |
| 10357 | DTI autoptx L3 atr l tract | GCST90385195 | 9.48e-04 |
| 10358 | aparc-a2009s lh area G+S-subcentral | GCST90003300 | 9.47e-04 |
| 10359 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T480 | ECGU000480 | 9.44e-04 |
| 10360 | Addison's disease | GCST90011871 | 9.43e-04 |
| 10361 | CCN2/EDAR ratio | GCST90313711 | 9.43e-04 |
| 10362 | IDP dMRI TBSS MD Superior fronto-occipital fasciculus R | GCST90004069 | 9.41e-04 |
| 10363 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T26 | ECGU000026 | 9.40e-04 |
| 10364 | Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers) | FING00000770 | 9.40e-04 |
| 10365 | Volume of left medial nucleus | GCST90474892 | 9.36e-04 |
| 10366 | Hydrocephalus | FING00000628 | 9.35e-04 |
| 10367 | Left-hemisphere default mode network to caudate white-matter structural connectivity | GCST90302768 | 9.35e-04 |
| 10368 | DTI autoptx L1 fmi tract | GCST90385150 | 9.35e-04 |
| 10369 | Fruit juice liking | GCST90094768 | 9.35e-04 |
| 10370 | FCRL1 levels | GCST90469205 | 9.35e-04 |
| 10371 | Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000177 | 9.34e-04 |
| 10372 | Cancer (UKB data field 2453) | GCST90043628 | 9.33e-04 |
| 10373 | Seropositive rheumatoid arthritis, wide | FING00001298 | 9.33e-04 |
| 10374 | GHRL levels | GCST90469341 | 9.33e-04 |
| 10375 | Seborrhoeic dermatitis | FING00001282 | 9.32e-04 |
| 10376 | AHSG levels | GCST90468263 | 9.31e-04 |
| 10377 | UXS1 levels | GCST90471023 | 9.30e-04 |
| 10378 | Knee extension strength | GCST90319502 | 9.29e-04 |
| 10379 | TCL1A/TNFRSF13C ratio | GCST90315912 | 9.27e-04 |
| 10380 | Alcohol drinker status: current vs never (UKB data field 20117) | GCST90132924 | 9.26e-04 |
| 10381 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T52 | ECGU000052 | 9.23e-04 |
| 10382 | IDP dMRI ProbtrackX ISOVF ilf l | GCST90004539 | 9.20e-04 |
| 10383 | IDP T1 FAST ROIs R intracalc cortex | GCST90002498 | 9.20e-04 |
| 10384 | Takes medication for Macular Degeneration? | GCST90475387 | 9.18e-04 |
| 10385 | T1 CAT volume L VIIIa | GCST90384127 | 9.16e-04 |
| 10386 | CALCOCO1/TJAP1 ratio | GCST90313611 | 9.14e-04 |
| 10387 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T437 | ECGA000437 | 9.13e-04 |
| 10388 | Peak expiratory flow | GCST007430 | 9.12e-04 |
| 10389 | Illnesses of mother - None of the above (group 1) | Family history | UKBB00000349 | 9.09e-04 |
| 10390 | MB levels | GCST90469869 | 9.08e-04 |
| 10391 | 1-palmitoylglycerophosphoethanolamine levels | GCST90243835 | 9.05e-04 |
| 10392 | CXCL10 levels | GCST90274780 | 9.04e-04 |
| 10393 | NH4_C22:4 Cholesteryl ester levels in chronic kidney disease | GCST90257227 | 9.03e-04 |
| 10394 | Sleep apnea with BMI < 30 | GCST90624797 | 8.97e-04 |
| 10395 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T459 | ECGA000459 | 8.97e-04 |
| 10396 | Methods of admission to hospital (recoded) - Elective admission: Planned | Summary Administration | UKBB00000462 | 8.95e-04 |
| 10397 | SCPEP1 levels | GCST90470553 | 8.91e-04 |
| 10398 | Atopic dermatitis | GCST90018564 | 8.91e-04 |
| 10399 | AGRP levels | GCST90012063 | 8.89e-04 |
| 10400 | Left-hemisphere default mode network to right-hemisphere limbic network white-matter structural connectivity | GCST90302764 | 8.87e-04 |
| 10401 | Left ventricular outflow tract obstruction, narrow definition | FING00000718 | 8.86e-04 |
| 10402 | Pregnancy with abortive outcome | FING00001205 | 8.86e-04 |
| 10403 | Hemoglobin A1c levels | GCST90278632 | 8.85e-04 |
| 10404 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T464 | ECGA000464 | 8.83e-04 |
| 10405 | EDAR/TXNDC5 ratio | GCST90314593 | 8.79e-04 |
| 10406 | aparc-Desikan rh area caudalmiddlefrontal | GCST90003110 | 8.75e-04 |
| 10407 | T1 FreeSurfer DKT lh precentral thickness | GCST90384246 | 8.75e-04 |
| 10408 | Thyrotoxicosis with diffuse goitre | FING00001361 | 8.68e-04 |
| 10409 | HLAE/IL15 ratio | GCST90315061 | 8.68e-04 |
| 10410 | SCGB1A1 levels | GCST90470540 | 8.67e-04 |
| 10411 | Retinal vascular disorders | FING00001262 | 8.67e-04 |
| 10412 | Other and unspecified psoriasis | FING00000950 | 8.66e-04 |
| 10413 | Testicular hypofunction (PheCode 257.1) | GCST90475697 | 8.66e-04 |
| 10414 | IDP dMRI TBSS L2 Posterior thalamic radiation L | GCST90004152 | 8.66e-04 |
| 10415 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T13 | ECGU000013 | 8.64e-04 |
| 10416 | aparc-a2009s lh area G-precuneus | GCST90003326 | 8.60e-04 |
| 10417 | Right-hemisphere visual network to amygdala white-matter structural connectivity | GCST90302786 | 8.51e-04 |
| 10418 | DSCAM levels | GCST90469041 | 8.47e-04 |
| 10419 | Diastolic blood pressure | GCST90301698 | 8.44e-04 |
| 10420 | Crohn's disease | GCST004132 | 8.41e-04 |
| 10421 | VEGFD levels | GCST90012069 | 8.38e-04 |
| 10422 | NRAC levels | GCST90617991 | 8.37e-04 |
| 10423 | Myasthenia gravis | GCST90432156 | 8.36e-04 |
| 10424 | BA-exvivo lh area BA6 | GCST90003213 | 8.35e-04 |
| 10425 | Snoring | Sleep | UKBB00000784 | 8.31e-04 |
| 10426 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T440 | ECGA000440 | 8.25e-04 |
| 10427 | Zoster infection | GCST90018721 | 8.24e-04 |
| 10428 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T40 | ECGU000040 | 8.21e-04 |
| 10429 | GZMH levels | GCST90469425 | 8.18e-04 |
| 10430 | IDO1 levels | GCST90469506 | 8.18e-04 |
| 10431 | Plasma X-24947 levels in chronic kidney disease | GCST90266816 | 8.18e-04 |
| 10432 | Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levels | GCST90060395 | 8.16e-04 |
| 10433 | PRR15 levels | GCST90424790 | 8.15e-04 |
| 10434 | Insomnia complaints | GCST006488 | 8.14e-04 |
| 10435 | wg lh intensity-contrast lateraloccipital | GCST90003802 | 8.13e-04 |
| 10436 | FCRL5/MZB1 ratio | GCST90314804 | 8.11e-04 |
| 10437 | Skin and soft tissue infections | GCST90013411 | 8.09e-04 |
| 10438 | CHGA levels | GCST90468741 | 8.06e-04 |
| 10439 | ITGB1BP2 levels | GCST90012058 | 8.06e-04 |
| 10440 | DAB2/LYN ratio | GCST90314365 | 8.05e-04 |
| 10441 | DEFA1 or DEFA1B levels | GCST90468979 | 8.02e-04 |
| 10442 | Total Ceramide levels | GCST90024578 | 8.01e-04 |
| 10443 | Nontoxic nodular goiter (PheCode 241) | GCST90475638 | 8.00e-04 |
| 10444 | Open-angle glaucoma (PheCode 365.1) | GCST90475872 | 7.99e-04 |
| 10445 | Operative procedures - Injection of therapeutic substance into joint | Summary Operations | UKBB00000582 | 7.98e-04 |
| 10446 | DSG3/FABP9 ratio | GCST90314559 | 7.97e-04 |
| 10447 | IDP dMRI TBSS L1 External capsule L | GCST90004108 | 7.94e-04 |
| 10448 | CLMP/PIK3IP1 ratio | GCST90314134 | 7.93e-04 |
| 10449 | CST5 levels | GCST90468895 | 7.91e-04 |
| 10450 | RETN/RNASET2 ratio | GCST90315768 | 7.90e-04 |
| 10451 | Prostate cancer | GCST90274714 | 7.90e-04 |
| 10452 | ABL1/CC2D1A ratio | GCST90313148 | 7.89e-04 |
| 10453 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T276 | ECGA000276 | 7.88e-04 |
| 10454 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T436 | ECGU000436 | 7.88e-04 |
| 10455 | IL12A or IL12B levels | GCST90469548 | 7.88e-04 |
| 10456 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T52 | ECGA000052 | 7.87e-04 |
| 10457 | Salami liking | GCST90094825 | 7.83e-04 |
| 10458 | FCRLB levels | GCST90469210 | 7.82e-04 |
| 10459 | Plasma methylsuccinoylcarnitine levels in chronic kidney disease | GCST90265508 | 7.82e-04 |
| 10460 | ARHGAP25 levels | GCST90468353 | 7.77e-04 |
| 10461 | Hernia abdominopelvic cavity | GCST90086087 | 7.74e-04 |
| 10462 | 1-margaroyl-2-linoleoyl-GPC (17:0/18:2) metabolite level | GCST90616013 | 7.73e-04 |
| 10463 | Coffee type - Instant coffee | Diet | UKBB00000141 | 7.70e-04 |
| 10464 | KLK8/WFDC12 ratio | GCST90315259 | 7.69e-04 |
| 10465 | CX3CL1 levels | GCST90241204 | 7.69e-04 |
| 10466 | aparc-a2009s rh thickness G-cuneus | GCST90003687 | 7.68e-04 |
| 10467 | All influenza | FING00000064 | 7.66e-04 |
| 10468 | CD20 on IgD- CD24- B cell | GCST90001753 | 7.66e-04 |
| 10469 | CD300E/CD59 ratio | GCST90313794 | 7.65e-04 |
| 10470 | TCN2 levels | GCST90470820 | 7.64e-04 |
| 10471 | CD63/EDAR ratio | GCST90313864 | 7.64e-04 |
| 10472 | DOK2/GRAP2 ratio | GCST90314531 | 7.61e-04 |
| 10473 | IDP T1 SIENAX white normalised volume | GCST90002432 | 7.49e-04 |
| 10474 | DTI TBSS FA External capsule R | GCST90384412 | 7.48e-04 |
| 10475 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82) | GCST90320901 | 7.47e-04 |
| 10476 | IDP T1 FAST ROIs R thalamus | GCST90002548 | 7.46e-04 |
| 10477 | PTPN1 levels | GCST90470376 | 7.45e-04 |
| 10478 | Myocardial fractal dimension (slice 3) | GCST90000289 | 7.41e-04 |
| 10479 | CCL7 levels | GCST90468585 | 7.41e-04 |
| 10480 | EGLN1 levels | GCST90469087 | 7.39e-04 |
| 10481 | Left-hemisphere visual network to left-hemisphere visual network white-matter structural connectivity | GCST90302648 | 7.36e-04 |
| 10482 | red blood cell count (RBC, mean, inv-norm transformed) | GCST90476347 | 7.33e-04 |
| 10483 | Female infertility, associated with anovulation | FING00000537 | 7.31e-04 |
| 10484 | IDP dMRI TBSS L3 Splenium of corpus callosum | GCST90004175 | 7.31e-04 |
| 10485 | CD46/TIMP1 ratio | GCST90313837 | 7.28e-04 |
| 10486 | T1 CAT volume L CingulateGyrusanteriordivision | GCST90384056 | 7.28e-04 |
| 10487 | Hyperthyroidism | GCST90319319 | 7.27e-04 |
| 10488 | PALM2 levels | GCST90470152 | 7.25e-04 |
| 10489 | Left-hemisphere control network to pallidum white-matter structural connectivity | GCST90302755 | 7.25e-04 |
| 10490 | Primary open angle glaucoma (PheCode 365.11) | GCST90475875 | 7.21e-04 |
| 10491 | aparc-a2009s rh volume G-precentral | GCST90003027 | 7.15e-04 |
| 10492 | Been in a confiding relationship as an adult | Traumatic events | UKBB00000088 | 7.14e-04 |
| 10493 | Allergic contact dermatitis | FING00000068 | 7.13e-04 |
| 10494 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T433 | ECGA000433 | 7.13e-04 |
| 10495 | Early age-related macular degeneration | GCST010723 | 7.12e-04 |
| 10496 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4) | GCST90320823 | 7.12e-04 |
| 10497 | FADD/PTPN6 ratio | GCST90314775 | 7.11e-04 |
| 10498 | aparc-pial rh area caudalmiddlefrontal | GCST90003177 | 7.10e-04 |
| 10499 | Kynurenine levels | GCST90243477 | 7.10e-04 |
| 10500 | Weight (minimum, inv-normal transformed) | GCST90476466 | 7.06e-04 |
| 10501 | IL2RA/NCR1 ratio | GCST90315161 | 7.04e-04 |
| 10502 | Qualifications - O levels/GCSEs or equivalent | Education | UKBB00000731 | 7.04e-04 |
| 10503 | Scar conditions and fibrosis of skin (PheCode 701.2) | GCST90476198 | 7.04e-04 |
| 10504 | Medication use (antihypertensives) | GCST90018764 | 7.03e-04 |
| 10505 | Attention deficit hyperactivity disorder (adjusted for age, sex) | GCST90275147 | 7.02e-04 |
| 10506 | Skin sebum (glabella) | GCST90502797 | 7.02e-04 |
| 10507 | Never eat eggs, dairy, wheat, sugar - Sugar or foods/drinks containing sugar | Diet | UKBB00000501 | 6.99e-04 |
| 10508 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T438 | ECGA000438 | 6.99e-04 |
| 10509 | Diverticulitis (PheCode 562.2) | GCST90476077 | 6.96e-04 |
| 10510 | SLAMF7/TXNDC15 ratio | GCST90315850 | 6.95e-04 |
| 10511 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T19 | ECGU000019 | 6.92e-04 |
| 10512 | SNAP29/SPARC ratio | GCST90315860 | 6.91e-04 |
| 10513 | Operation code - tonsillectomy +/- adenoids | Operations | UKBB00000567 | 6.91e-04 |
| 10514 | KLK11/KLK8 ratio | GCST90315254 | 6.89e-04 |
| 10515 | IBD (strict) with PSC | FING00000657 | 6.87e-04 |
| 10516 | PSPN levels | GCST90470364 | 6.85e-04 |
| 10517 | CD69/CEP43 ratio | GCST90313867 | 6.84e-04 |
| 10518 | IDP dMRI TBSS MO Middle cerebellar peduncle | GCST90003952 | 6.84e-04 |
| 10519 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T446 | ECGA000446 | 6.84e-04 |
| 10520 | DTI autoptx MD atr l tract | GCST90385222 | 6.83e-04 |
| 10521 | Plasma methylsuccinate levels in chronic kidney disease | GCST90265506 | 6.83e-04 |
| 10522 | HS6ST2 levels | GCST90469480 | 6.81e-04 |
| 10523 | EDN1 levels | GCST90469073 | 6.80e-04 |
| 10524 | Operative procedures - Direct current cardioversion | Summary Operations | UKBB00000576 | 6.79e-04 |
| 10525 | CD160 levels | GCST90468599 | 6.78e-04 |
| 10526 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T219 | ECGU000219 | 6.78e-04 |
| 10527 | Turnip liking | GCST90094861 | 6.77e-04 |
| 10528 | Chronic obstructive pulmonary disease in non-current smokers | GCST90016594 | 6.74e-04 |
| 10529 | Malignant melanoma, excluding all cancers (controls excluding all cancers) | FING00000750 | 6.73e-04 |
| 10530 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T51 | ECGU000051 | 6.73e-04 |
| 10531 | Principal component-derived dietary pattern 21 | GCST90133026 | 6.72e-04 |
| 10532 | CCN3 levels | GCST90242492 | 6.70e-04 |
| 10533 | IGLC2 levels | GCST90469536 | 6.70e-04 |
| 10534 | THY1 levels | GCST90470861 | 6.68e-04 |
| 10535 | Volume of right paralaminar nucleus | GCST90475051 | 6.67e-04 |
| 10536 | LGALS1 levels | GCST90469759 | 6.67e-04 |
| 10537 | diastolic blood pressure (DBP, maximum, inv-normal transformed) | GCST90475252 | 6.66e-04 |
| 10538 | Left-hemisphere visual network to accumbens white-matter structural connectivity | GCST90302668 | 6.66e-04 |
| 10539 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T231 | ECGA000231 | 6.66e-04 |
| 10540 | IDP dMRI TBSS L1 Sagittal stratum R | GCST90004105 | 6.63e-04 |
| 10541 | aparc-pial rh area inferiorparietal | GCST90003181 | 6.62e-04 |
| 10542 | Acute alcohol intoxication, ICD10 | FING00000015 | 6.60e-04 |
| 10543 | ICAM3/SLAMF7 ratio | GCST90315123 | 6.59e-04 |
| 10544 | eosinophil (fraction, maximum, inv-norm transformed) | GCST90475297 | 6.58e-04 |
| 10545 | ERBIN/SNAP29 ratio | GCST90314697 | 6.58e-04 |
| 10546 | GPKOW levels | GCST90469392 | 6.57e-04 |
| 10547 | FLT3LG levels | GCST90274791 | 6.56e-04 |
| 10548 | HippSubfield lh volume CA3-body | GCST90002680 | 6.51e-04 |
| 10549 | Cancer of urinary organs (incl. kidney and bladder) (PheCode 189) | GCST90475593 | 6.51e-04 |
| 10550 | Snoring | GCST009760 | 6.50e-04 |
| 10551 | Diseases of the digestive system | FING00000429 | 6.49e-04 |
| 10552 | Insulin fold change during an oral glucose tolerance test (adjusted for BMI) | GCST90267567 | 6.47e-04 |
| 10553 | Melanomas of skin (PheCode 172.11) | GCST90475578 | 6.46e-04 |
| 10554 | AmygNuclei rh volume Medial-nucleus | GCST90002663 | 6.44e-04 |
| 10555 | Facial wrinkles (under eye) | GCST90094903 | 6.44e-04 |
| 10556 | GUCA2A/LGALS4 ratio | GCST90314998 | 6.42e-04 |
| 10557 | ANXA3/ANXA4 ratio | GCST90313278 | 6.42e-04 |
| 10558 | Peritonsillar abscess | FING00001160 | 6.42e-04 |
| 10559 | Total bile acid levels in pregnancy | GCST90454198 | 6.41e-04 |
| 10560 | RELT levels | GCST90470453 | 6.41e-04 |
| 10561 | Second line medication for Crohn's disease | FING00001284 | 6.40e-04 |
| 10562 | GSTA1/RBP5 ratio | GCST90314995 | 6.40e-04 |
| 10563 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81) | GCST90320644 | 6.39e-04 |
| 10564 | IDP dMRI ProbtrackX FA ar r | GCST90003926 | 6.38e-04 |
| 10565 | aparc-DKTatlas lh area pericalcarine | GCST90003253 | 6.34e-04 |
| 10566 | CD84/GP6 ratio | GCST90313914 | 6.33e-04 |
| 10567 | TACC3/TBC1D23 ratio | GCST90315900 | 6.31e-04 |
| 10568 | Myocardial fractal dimension (slice 6) | GCST90000292 | 6.26e-04 |
| 10569 | TRIM40 levels | GCST90470968 | 6.25e-04 |
| 10570 | Eosinophill percentage | Blood count | UKBB00000207 | 6.19e-04 |
| 10571 | Acute pancreatitis | GCST90255375 | 6.17e-04 |
| 10572 | Tyrosine levels | GCST90200427 | 6.16e-04 |
| 10573 | Right-hemisphere default mode network to hippocampus white-matter structural connectivity | GCST90302848 | 6.15e-04 |
| 10574 | Left ventricular end systole inferior wall thickness | GCST90278509 | 6.13e-04 |
| 10575 | Dizziness and giddiness (Light-headedness and vertigo) (PheCode 386.9) | GCST90475908 | 6.12e-04 |
| 10576 | SAP18 levels | GCST90241432 | 6.11e-04 |
| 10577 | Erysipelas | FING00000518 | 6.09e-04 |
| 10578 | FSTL3/SPON2 ratio | GCST90314884 | 6.08e-04 |
| 10579 | Falls in the last year | General health | UKBB00000235 | 6.06e-04 |
| 10580 | Birth asphyxia | FING00000218 | 6.05e-04 |
| 10581 | IDP dMRI TBSS MO Anterior corona radiata R | GCST90003974 | 6.05e-04 |
| 10582 | ATOX1/SNAP29 ratio | GCST90313374 | 6.03e-04 |
| 10583 | AMBN levels | GCST90468287 | 6.00e-04 |
| 10584 | Sleep disorders (PheCode 327) | GCST90475823 | 6.00e-04 |
| 10585 | Plasma iron levels | GCST90100546 | 6.00e-04 |
| 10586 | CXCL5/MESD ratio | GCST90314350 | 5.99e-04 |
| 10587 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T428 | ECGA000428 | 5.98e-04 |
| 10588 | CCL4 levels | GCST004433 | 5.97e-04 |
| 10589 | SERPINB1/TMSB10 ratio | GCST90315830 | 5.96e-04 |
| 10590 | FCRL2/LY9 ratio | GCST90314799 | 5.95e-04 |
| 10591 | ART3/RGMB ratio | GCST90313363 | 5.95e-04 |
| 10592 | Type 2 diabetes | GCST90018706 | 5.93e-04 |
| 10593 | Lifespan | GCST90551886 | 5.93e-04 |
| 10594 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 5) | GCST90320568 | 5.90e-04 |
| 10595 | Mean arterial pressure | GCST90018743 | 5.89e-04 |
| 10596 | KLK8/LY6D ratio | GCST90315257 | 5.89e-04 |
| 10597 | Prescriptions - prostaglandin analog | UKBB00000697 | 5.89e-04 |
| 10598 | LMNB1 levels | GCST90469781 | 5.89e-04 |
| 10599 | CALCOCO1/IKBKG ratio | GCST90313602 | 5.88e-04 |
| 10600 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320641 | 5.88e-04 |
| 10601 | Smoking status (weighted GWA) | GCST90267303 | 5.86e-04 |
| 10602 | CD40LG/TNFSF14 ratio | GCST90313827 | 5.86e-04 |
| 10603 | CFHR1 levels | GCST90618503 | 5.83e-04 |
| 10604 | Tyrosine levels (UKB data field 23469) | GCST90269566 | 5.82e-04 |
| 10605 | Use of sun/uv protection | Sun exposure | UKBB00000887 | 5.81e-04 |
| 10606 | N-formylanthranilic acid levels | GCST90199960 | 5.80e-04 |
| 10607 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79) | GCST90320642 | 5.80e-04 |
| 10608 | Chronic obstructive pulmonary disease x current smoker interaction (main effect) | GCST90016591 | 5.79e-04 |
| 10609 | C4BPB/ENTPD5 ratio | GCST90313556 | 5.78e-04 |
| 10610 | Systolic blood pressure | GCST90472780 | 5.78e-04 |
| 10611 | LAT2/MANF ratio | GCST90315277 | 5.77e-04 |
| 10612 | Octadecanedioylcarnitine (C18-DC) levels | GCST90199992 | 5.75e-04 |
| 10613 | Ganglion | FING00000563 | 5.72e-04 |
| 10614 | CCL4 levels | GCST90012052 | 5.70e-04 |
| 10615 | Hypoplasia of dental enamel, including avohilmo | FING00000652 | 5.70e-04 |
| 10616 | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | GCST90004117 | 5.70e-04 |
| 10617 | CD19 on IgD- CD38- B cell | GCST90001733 | 5.70e-04 |
| 10618 | Glaucoma | GCST90468129 | 5.66e-04 |
| 10619 | ICD10 O12: Gestational oedema and proteinuria without hypertension | GCST90454231 | 5.66e-04 |
| 10620 | IDP T1 FAST ROIs R planum temporale | GCST90002542 | 5.62e-04 |
| 10621 | Lysoalkylphosphatidylcholine (O-22:0) levels | GCST90024195 | 5.61e-04 |
| 10622 | BCL2 levels | GCST90468433 | 5.60e-04 |
| 10623 | SSC4D levels | GCST90470747 | 5.59e-04 |
| 10624 | Mandibular retrognathia | FING00000784 | 5.58e-04 |
| 10625 | Principal component-derived dietary pattern 20 | GCST90133025 | 5.57e-04 |
| 10626 | IFNLR1 levels | GCST90469518 | 5.56e-04 |
| 10627 | Cerebrospinal fluid methylmalonate (MMA) levels | GCST90318243 | 5.55e-04 |
| 10628 | Treatment or medication use - ezetimibe (UKB data field 20003_1141192736) | GCST90042541 | 5.54e-04 |
| 10629 | KRT8 levels | GCST90469720 | 5.52e-04 |
| 10630 | KITLG levels | GCST90428432 | 5.51e-04 |
| 10631 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T98 | ECGA000098 | 5.48e-04 |
| 10632 | Hypertension, essential | FING00000638 | 5.46e-04 |
| 10633 | Other specified cardiac dysrhythmias (PheCode 427.3) | GCST90475975 | 5.44e-04 |
| 10634 | DFFA/FOXO1 ratio | GCST90314456 | 5.43e-04 |
| 10635 | ThalamNuclei rh volume MGN | GCST90002737 | 5.43e-04 |
| 10636 | CEP85/ZBTB16 ratio | GCST90314026 | 5.43e-04 |
| 10637 | TNFRSF17 levels | GCST90470908 | 5.39e-04 |
| 10638 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47) | GCST90320610 | 5.36e-04 |
| 10639 | CX3CL1/EPHB6 ratio | GCST90314324 | 5.33e-04 |
| 10640 | ThalamNuclei lh volume PuA | GCST90002720 | 5.32e-04 |
| 10641 | OMG levels | GCST90470124 | 5.32e-04 |
| 10642 | MST1 levels | GCST90469952 | 5.30e-04 |
| 10643 | CD69/CDKN2D ratio | GCST90313866 | 5.30e-04 |
| 10644 | Right-hemisphere somatomotor network to right-hemisphere default mode network white-matter structural connectivity | GCST90302793 | 5.29e-04 |
| 10645 | aparc-a2009s lh volume G-pariet-inf-Supramar | GCST90002950 | 5.29e-04 |
| 10646 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T73 | ECGA000073 | 5.26e-04 |
| 10647 | Plasma 2-aminobutyrate levels in chronic kidney disease | GCST90264339 | 5.26e-04 |
| 10648 | AmygNuclei rh volume Central-nucleus | GCST90002662 | 5.23e-04 |
| 10649 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T14 | ECGU000014 | 5.23e-04 |
| 10650 | FOXO3 levels | GCST90469266 | 5.19e-04 |
| 10651 | T1 FreeSurfer aseg Brain-Stem | GCST90384149 | 5.17e-04 |
| 10652 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T432 | ECGA000432 | 5.16e-04 |
| 10653 | Illnesses of siblings - None of the above (group 1) | Family history | UKBB00000353 | 5.16e-04 |
| 10654 | Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers) | FING00000864 | 5.15e-04 |
| 10655 | Cardiometabolic multimorbidity | GCST90274723 | 5.15e-04 |
| 10656 | FAM3B levels | GCST90469186 | 5.14e-04 |
| 10657 | LYN/TACC3 ratio | GCST90315350 | 5.14e-04 |
| 10658 | Smoked fish liking | GCST90094841 | 5.14e-04 |
| 10659 | Treatment or medication use - amlodipine (UKB data field 20003_1140879802) | GCST90042195 | 5.13e-04 |
| 10660 | Diverticular disease of intestine | FING00000471 | 5.13e-04 |
| 10661 | FCAR/LY96 ratio | GCST90314788 | 5.11e-04 |
| 10662 | Sphingomyelin (d18:1/20:0, d16:1/22:0) levels | GCST90200001 | 5.09e-04 |
| 10663 | FYN levels | GCST90243200 | 5.09e-04 |
| 10664 | IDP dMRI TBSS L1 Posterior corona radiata L | GCST90004102 | 5.06e-04 |
| 10665 | Systolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000807 | 5.04e-04 |
| 10666 | Systolic blood pressure, automated reading | Blood pressure | UKBB00000803 | 5.02e-04 |
| 10667 | SIRPB1 levels | GCST90470640 | 5.02e-04 |
| 10668 | CHCHD6 levels | GCST90468739 | 5.02e-04 |
| 10669 | S100A11/SERPINB8 ratio | GCST90315799 | 5.00e-04 |
| 10670 | CA1/CA3 ratio | GCST90313572 | 4.98e-04 |
| 10671 | Emphysema | FING00000496 | 4.96e-04 |
| 10672 | Celiac disease (PheCode 557.1) | GCST90044158 | 4.95e-04 |
| 10673 | Pulmonary fibrosis | GCST90018688 | 4.95e-04 |
| 10674 | EBAG9/TBCB ratio | GCST90314567 | 4.94e-04 |
| 10675 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T455 | ECGA000455 | 4.91e-04 |
| 10676 | Prostate cancer | GCST90428117 | 4.89e-04 |
| 10677 | TNFRSF19 levels | GCST90470909 | 4.88e-04 |
| 10678 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T435 | ECGU000435 | 4.88e-04 |
| 10679 | N-palmitoyl-heptadecasphingosine (d17:1/16:0) levels | GCST90200115 | 4.88e-04 |
| 10680 | SPINT1 levels | GCST90241717 | 4.87e-04 |
| 10681 | Excessive vomiting in pregnancy | FING00000523 | 4.87e-04 |
| 10682 | Suggestive for eosinophilic asthma | FING00001344 | 4.87e-04 |
| 10683 | Polyglandular dysfunction | FING00001186 | 4.86e-04 |
| 10684 | Glaucoma | GCST90018632 | 4.83e-04 |
| 10685 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T16 | ECGU000016 | 4.83e-04 |
| 10686 | Cleft hard palate NOS | FING00000306 | 4.83e-04 |
| 10687 | Myopia | FING00000853 | 4.82e-04 |
| 10688 | Illnesses of father - High blood pressure | Family history | UKBB00000343 | 4.81e-04 |
| 10689 | Systolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000806 | 4.81e-04 |
| 10690 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T70 | ECGA000070 | 4.80e-04 |
| 10691 | Total bilirubin levels (UKB data field 30840) | GCST90468104 | 4.80e-04 |
| 10692 | Plantar fascial fibromatosis | FING00001169 | 4.79e-04 |
| 10693 | MANF/PTPN6 ratio | GCST90315366 | 4.79e-04 |
| 10694 | Seminoma of testis, excluding all cancers (controls excluding all cancers) | FING00001289 | 4.78e-04 |
| 10695 | RCC1 levels | GCST90470443 | 4.77e-04 |
| 10696 | Prostate cancer | GCST006085 | 4.75e-04 |
| 10697 | IDP T1 FAST ROIs L cuneal cortex | GCST90002513 | 4.75e-04 |
| 10698 | Physical activity (standard GWA) | GCST90267292 | 4.74e-04 |
| 10699 | Cancer code, self-reported: prostate cancer (UKB data field 20001_1044) | GCST90041905 | 4.73e-04 |
| 10700 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 30) | GCST90320849 | 4.72e-04 |
| 10701 | aparc-a2009s rh thickness G-temporal-middle | GCST90003714 | 4.70e-04 |
| 10702 | Open bite | FING00000903 | 4.70e-04 |
| 10703 | Cataracts | GCST90475382 | 4.68e-04 |
| 10704 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T260 | ECGA000260 | 4.65e-04 |
| 10705 | PCSK7 levels | GCST90470176 | 4.63e-04 |
| 10706 | Right subiculum volume (body) | GCST90267980 | 4.62e-04 |
| 10707 | Sleep duration | Sleep | UKBB00000777 | 4.59e-04 |
| 10708 | Ratio of bis-allylic bonds to double bonds in lipids | GCST90132744 | 4.57e-04 |
| 10709 | Erectile dysfunction [ED] (PheCode 605) | GCST90476161 | 4.55e-04 |
| 10710 | ADH1B levels | GCST90468243 | 4.54e-04 |
| 10711 | CCL17/PDGFB ratio | GCST90313688 | 4.54e-04 |
| 10712 | RGMB/SMOC2 ratio | GCST90315770 | 4.53e-04 |
| 10713 | Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers) | FING00001330 | 4.53e-04 |
| 10714 | aseg lh volume Inf-Lat-Vent | GCST90002617 | 4.52e-04 |
| 10715 | Pre-eclampsia or eclampsia | FING00001201 | 4.47e-04 |
| 10716 | Biological Sibling: Asthma | GCST90476372 | 4.47e-04 |
| 10717 | Allergic asthma (mode) | FING00000066 | 4.46e-04 |
| 10718 | X-21286 levels | GCST90200562 | 4.45e-04 |
| 10719 | CSTB levels | GCST90179272 | 4.45e-04 |
| 10720 | Pollen allergy | FING00001176 | 4.41e-04 |
| 10721 | ANXA3/SERPINB1 ratio | GCST90313289 | 4.41e-04 |
| 10722 | PLIN1 levels | GCST90470258 | 4.40e-04 |
| 10723 | Other disorders of glucose regulation and pancreatic internal secretion | FING00001028 | 4.39e-04 |
| 10724 | Processed meat consumption | GCST90132995 | 4.38e-04 |
| 10725 | Cerebral aneurysm, nonruptured | FING00000263 | 4.35e-04 |
| 10726 | IDP dMRI TBSS OD Pontine crossing tract | GCST90004403 | 4.35e-04 |
| 10727 | Operative procedures - Closed reduction of fracture of bone and fixation using nail or screw | Summary Operations | UKBB00000575 | 4.34e-04 |
| 10728 | Left ventricle sphericity index | GCST90268402 | 4.32e-04 |
| 10729 | T1 FreeSurfer a2009s lh S postcentral area | GCST90384734 | 4.32e-04 |
| 10730 | EZR levels | GCST90469162 | 4.30e-04 |
| 10731 | Primary biliary cholangitis | GCST003129 | 4.29e-04 |
| 10732 | Falling risk | GCST90012857 | 4.27e-04 |
| 10733 | REST UKBBICA NODEamps25 0003 | GCST90385486 | 4.26e-04 |
| 10734 | EDAR/TNFSF12 ratio | GCST90314591 | 4.26e-04 |
| 10735 | Chronic ulcer of skin, not elsewhere classified | FING00000300 | 4.25e-04 |
| 10736 | CD8A levels | GCST90468655 | 4.25e-04 |
| 10737 | Body mass index (BMI, mean, inv-normal transformed) | GCST90475156 | 4.25e-04 |
| 10738 | COLEC12/NBL1 ratio | GCST90314183 | 4.25e-04 |
| 10739 | F-glutamate liking (derived food-liking factor) | GCST90094772 | 4.24e-04 |
| 10740 | PPP1R12A/SPARC ratio | GCST90315712 | 4.23e-04 |
| 10741 | PAEP levels | GCST90470144 | 4.23e-04 |
| 10742 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T20 | ECGU000020 | 4.22e-04 |
| 10743 | DTI TBSS FA Anterior corona radiata L | GCST90384403 | 4.21e-04 |
| 10744 | SEPHS1 levels | GCST90242740 | 4.19e-04 |
| 10745 | ADIPOQ levels | GCST90468245 | 4.19e-04 |
| 10746 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118) | GCST90320681 | 4.17e-04 |
| 10747 | X-11786--methylcysteine levels | GCST90243654 | 4.16e-04 |
| 10748 | Maximum digits remembered correctly | Numeric memory | UKBB00000430 | 4.16e-04 |
| 10749 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T439 | ECGA000439 | 4.15e-04 |
| 10750 | Atrial fibrillation and flutter with reimbursement | FING00000127 | 4.14e-04 |
| 10751 | ARHGAP25/RNF41 ratio | GCST90313345 | 4.13e-04 |
| 10752 | SLAMF1 levels | GCST90274835 | 4.13e-04 |
| 10753 | CLEC1B/PPP1R2 ratio | GCST90314101 | 4.11e-04 |
| 10754 | Friendships satisfaction | Mental health | UKBB00000273 | 4.11e-04 |
| 10755 | Hyperparathyroidism (PheCode 252.1) | GCST90475693 | 4.10e-04 |
| 10756 | DTI TBSS L1 Cingulum cingulate gyrus L | GCST90384463 | 4.10e-04 |
| 10757 | Volume of right central nucleus | GCST90475027 | 4.08e-04 |
| 10758 | Glucose levels | GCST90018735 | 4.08e-04 |
| 10759 | Skin color (cheek, ITA value) | GCST90502780 | 4.07e-04 |
| 10760 | EDAR/F11R ratio | GCST90314576 | 4.07e-04 |
| 10761 | Asthma (only as main-diagnosis) (more control exclusions) | FING00000114 | 4.06e-04 |
| 10762 | eosinophil (fraction, mean, inv-norm transformed) | GCST90475300 | 4.06e-04 |
| 10763 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T469 | ECGA000469 | 4.04e-04 |
| 10764 | CASP3/SNAP23 ratio | GCST90313644 | 4.01e-04 |
| 10765 | PODXL2 levels | GCST90470279 | 3.97e-04 |
| 10766 | IDP dMRI TBSS L3 Retrolenticular part of internal capsule R | GCST90004191 | 3.96e-04 |
| 10767 | Skin cancer | GCST90475575 | 3.94e-04 |
| 10768 | Random glucose levels | GCST90271557 | 3.93e-04 |
| 10769 | CA13/TYMP ratio | GCST90313568 | 3.92e-04 |
| 10770 | Guilty feelings | Mental health | UKBB00000291 | 3.92e-04 |
| 10771 | Hyperthyroidism | GCST90468136 | 3.92e-04 |
| 10772 | Retinal detachments and breaks | FING00001260 | 3.92e-04 |
| 10773 | Vitamin and mineral supplements - None of the above | Medication | UKBB00000901 | 3.91e-04 |
| 10774 | PDCD1 levels | GCST90470181 | 3.91e-04 |
| 10775 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T18 | ECGU000018 | 3.90e-04 |
| 10776 | CD40/GLOD4 ratio | GCST90313814 | 3.90e-04 |
| 10777 | ATG4A/TPMT ratio | GCST90313370 | 3.89e-04 |
| 10778 | FUT8 levels | GCST90469281 | 3.88e-04 |
| 10779 | Renal tubulo-interstitial diseases | FING00001251 | 3.87e-04 |
| 10780 | Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers) | FING00000755 | 3.87e-04 |
| 10781 | Other symptoms of respiratory system (PheCode 512) | GCST90476039 | 3.82e-04 |
| 10782 | CXCL5/PPIB ratio | GCST90314352 | 3.80e-04 |
| 10783 | CXCL5/EDAR ratio | GCST90314349 | 3.79e-04 |
| 10784 | DPP7 levels | GCST90469035 | 3.79e-04 |
| 10785 | DTI autoptx FA ifo r tract | GCST90385125 | 3.77e-04 |
| 10786 | Inflammatory bowel disease, strict (require KELA) | FING00000675 | 3.77e-04 |
| 10787 | CD74/JAM2 ratio | GCST90313893 | 3.77e-04 |
| 10788 | Acute sinusitis | FING00000031 | 3.77e-04 |
| 10789 | aparc-DKTatlas rh volume parsopercularis | GCST90002909 | 3.75e-04 |
| 10790 | PPY levels | GCST90470309 | 3.74e-04 |
| 10791 | Gamma-CEHC glucuronide levels | GCST90199941 | 3.73e-04 |
| 10792 | Macular pucker | FING00000745 | 3.73e-04 |
| 10793 | LCN2/PRTN3 ratio | GCST90315307 | 3.72e-04 |
| 10794 | ENO2/HCLS1 ratio | GCST90314660 | 3.72e-04 |
| 10795 | Other demyelinating diseases of the central nervous system | FING00000995 | 3.72e-04 |
| 10796 | FCER2/TNFRSF9 ratio | GCST90314791 | 3.72e-04 |
| 10797 | Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000178 | 3.71e-04 |
| 10798 | aparc-a2009s lh volume G-oc-temp-med-Lingual | GCST90002946 | 3.70e-04 |
| 10799 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54) | GCST90320617 | 3.70e-04 |
| 10800 | IDP T1 FAST ROIs L parahipp gyrus post | GCST90002519 | 3.69e-04 |
| 10801 | Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers) | FING00000777 | 3.68e-04 |
| 10802 | aparc-Desikan rh area parstriangularis | GCST90003126 | 3.68e-04 |
| 10803 | aparc-Desikan rh volume precentral | GCST90002824 | 3.67e-04 |
| 10804 | Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified | FING00000431 | 3.67e-04 |
| 10805 | CCL2 levels | GCST90012007 | 3.67e-04 |
| 10806 | Cancer | GCST90086052 | 3.65e-04 |
| 10807 | CYTL1 levels | GCST90468940 | 3.65e-04 |
| 10808 | Phospholipid levels in very small VLDL | GCST90132659 | 3.64e-04 |
| 10809 | CCN2/TACC3 ratio | GCST90313717 | 3.64e-04 |
| 10810 | Abnormal findings examination of lungs (PheCode 514) | GCST90476043 | 3.64e-04 |
| 10811 | LGALS4/TIE1 ratio | GCST90315316 | 3.61e-04 |
| 10812 | Left-hemisphere somatomotor network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302677 | 3.59e-04 |
| 10813 | HDAC8 levels | GCST90469438 | 3.58e-04 |
| 10814 | Prevotella sp000434975 abundance in stool | GCST90032518 | 3.57e-04 |
| 10815 | IDP dMRI TBSS MD Posterior thalamic radiation L | GCST90004056 | 3.56e-04 |
| 10816 | CLIC5 levels | GCST90421740 | 3.56e-04 |
| 10817 | LGALS3 levels | GCST90012009 | 3.55e-04 |
| 10818 | ECHDC3 levels | GCST90469062 | 3.55e-04 |
| 10819 | Frequency of stair climbing in last 4 weeks | Physical activity | UKBB00000266 | 3.54e-04 |
| 10820 | Other disorders of synovium, tendon, and bursa (PheCode 727) | GCST90476241 | 3.53e-04 |
| 10821 | Hemoglobin A1c levels | GCST90018738 | 3.53e-04 |
| 10822 | Breast cancer | GCST90429846 | 3.52e-04 |
| 10823 | TNFRSF1B levels | GCST90012026 | 3.52e-04 |
| 10824 | Flat foot [pes planus] (acquired) | FING00000545 | 3.51e-04 |
| 10825 | PIKFYVE levels | GCST90470235 | 3.50e-04 |
| 10826 | Epstein-Barr virus EA-D antibody levels | GCST90006898 | 3.50e-04 |
| 10827 | Hip width to body height ratio | GCST90270260 | 3.50e-04 |
| 10828 | Diastolic blood pressure | GCST90278625 | 3.49e-04 |
| 10829 | rfMRI connectivity ICA-features 4 | GCST90006342 | 3.46e-04 |
| 10830 | Lymphangioleiomyomatosis (sporadic) | GCST008311 | 3.46e-04 |
| 10831 | JCHAIN levels | GCST90469661 | 3.46e-04 |
| 10832 | VEGFD levels | GCST90471037 | 3.46e-04 |
| 10833 | Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levels | GCST90024504 | 3.46e-04 |
| 10834 | Hypertension | FING00000637 | 3.45e-04 |
| 10835 | ICA1/MVK ratio | GCST90315108 | 3.43e-04 |
| 10836 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2) | GCST90320821 | 3.43e-04 |
| 10837 | aparc-Desikan lh area pericalcarine | GCST90003093 | 3.42e-04 |
| 10838 | IL5RA/TNFRSF13B ratio | GCST90315164 | 3.42e-04 |
| 10839 | Sphingomyelin (d16:1/23:0) levels/Sphingomyelin (d17:1/22:0) levels | GCST90025735 | 3.41e-04 |
| 10840 | CD27/NBL1 ratio | GCST90313774 | 3.39e-04 |
| 10841 | MZB1/TNFRSF13B ratio | GCST90315509 | 3.39e-04 |
| 10842 | CA1 levels | GCST90468510 | 3.38e-04 |
| 10843 | ALCAM/SPINT1 ratio | GCST90313242 | 3.37e-04 |
| 10844 | GP6/TMSB10 ratio | GCST90314975 | 3.37e-04 |
| 10845 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T141 | ECGU000141 | 3.37e-04 |
| 10846 | Osteoporosis | FING00000914 | 3.33e-04 |
| 10847 | EGLN1/FOXO1 ratio | GCST90314616 | 3.32e-04 |
| 10848 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T31 | ECGU000031 | 3.32e-04 |
| 10849 | GPLD1 levels | GCST90086890 | 3.32e-04 |
| 10850 | CXCL5/SPARC ratio | GCST90314355 | 3.31e-04 |
| 10851 | Never eat sugar vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144) | GCST90132933 | 3.31e-04 |
| 10852 | aparc-a2009s rh thickness Pole-temporal | GCST90003719 | 3.30e-04 |
| 10853 | Disorders of bilirubin excretion (PheCode 277.4) | GCST90475756 | 3.29e-04 |
| 10854 | CXCL9 levels | GCST90468935 | 3.28e-04 |
| 10855 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T434 | ECGA000434 | 3.28e-04 |
| 10856 | TGOLN2 levels | GCST90470850 | 3.28e-04 |
| 10857 | Corneal opacity and other disorders of cornea (PheCode 364) | GCST90475861 | 3.24e-04 |
| 10858 | Alkylphosphatidylcholine (O-34:1) levels | GCST90024925 | 3.23e-04 |
| 10859 | Number of sexual partners in opposite-sex sexual behavior | GCST90026481 | 3.21e-04 |
| 10860 | Added salt consumption | GCST90133001 | 3.20e-04 |
| 10861 | Volume of right basal nucleus | GCST90475015 | 3.19e-04 |
| 10862 | Non-cancer illness code, self-reported - eczema/dermatitis | Medical conditions | UKBB00000509 | 3.18e-04 |
| 10863 | SCGB3A1 levels | GCST90470542 | 3.18e-04 |
| 10864 | eGFR in diabetes mellitus (strict) case-control group (minimal adjustment) | GCST90624781 | 3.17e-04 |
| 10865 | Neutrophil percentage of white cells variance | GCST90565701 | 3.17e-04 |
| 10866 | CBLIF levels | GCST90468552 | 3.17e-04 |
| 10867 | Dermatitis and eczema | FING00000402 | 3.17e-04 |
| 10868 | NPHS2 levels | GCST90470071 | 3.15e-04 |
| 10869 | TIMP4 levels | GCST90470872 | 3.15e-04 |
| 10870 | Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+NH4]1+ levels | GCST90060325 | 3.15e-04 |
| 10871 | Ulcerative colitis | GCST90018713 | 3.14e-04 |
| 10872 | TG levels | GCST90470851 | 3.14e-04 |
| 10873 | ISEI occupational score | GCST90446160 | 3.13e-04 |
| 10874 | BCR/FOXO1 ratio | GCST90313490 | 3.13e-04 |
| 10875 | Eosinophil count | GCST90002298 | 3.12e-04 |
| 10876 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T128 | ECGA000128 | 3.11e-04 |
| 10877 | Autoimmune diseases | FING00000131 | 3.11e-04 |
| 10878 | Snoring | GCST009761 | 3.11e-04 |
| 10879 | AmygNuclei rh volume Lateral-nucleus | GCST90002658 | 3.11e-04 |
| 10880 | IDP dMRI TBSS FA Retrolenticular part of internal capsule R | GCST90003897 | 3.09e-04 |
| 10881 | Systolic blood pressure | GCST90025968 | 3.09e-04 |
| 10882 | IDP T1 SIENAX white unnormalised volume | GCST90002433 | 3.08e-04 |
| 10883 | Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000809 | 3.07e-04 |
| 10884 | FSTL3 levels | GCST90425765 | 3.07e-04 |
| 10885 | NUDT5/SERPINB1 ratio | GCST90315581 | 3.05e-04 |
| 10886 | Left-hemisphere visual network to left-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302651 | 3.05e-04 |
| 10887 | Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000179 | 3.03e-04 |
| 10888 | Osteoporosis, osteopenia and pathological fracture | musculoskeletal | UKBB00000600 | 3.03e-04 |
| 10889 | Testicular dysfunction (PheCode 257) | GCST90475696 | 3.02e-04 |
| 10890 | CD5 levels | GCST90468641 | 3.02e-04 |
| 10891 | CAPN3 levels | GCST90468538 | 3.02e-04 |
| 10892 | IDP dMRI TBSS L1 Anterior limb of internal capsule L | GCST90004092 | 3.01e-04 |
| 10893 | PLXDC1 levels | GCST90470263 | 3.01e-04 |
| 10894 | TPM2 levels | GCST90243122 | 3.01e-04 |
| 10895 | X-13435 levels | GCST90243811 | 3.01e-04 |
| 10896 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 95) | GCST90320658 | 2.98e-04 |
| 10897 | Systolic blood pressure | GCST90472782 | 2.98e-04 |
| 10898 | aparc-pial rh area precuneus | GCST90003198 | 2.97e-04 |
| 10899 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T72 | ECGA000072 | 2.97e-04 |
| 10900 | T1 CAT volume R SupramarginalGyrusanteriordivision | GCST90384037 | 2.97e-04 |
| 10901 | PER3 levels | GCST90470210 | 2.96e-04 |
| 10902 | Bullous keratopathy | FING00000231 | 2.94e-04 |
| 10903 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T135 | ECGU000135 | 2.93e-04 |
| 10904 | Coeliac disease | GCST90468120 | 2.93e-04 |
| 10905 | aparc-DKTatlas lh area entorhinal | GCST90003238 | 2.92e-04 |
| 10906 | PPME1/PSMD9 ratio | GCST90315705 | 2.92e-04 |
| 10907 | GAST levels | GCST90469307 | 2.92e-04 |
| 10908 | HippSubfield rh volume Whole-hippocampal-head | GCST90002710 | 2.91e-04 |
| 10909 | Crohn's disease | GCST90475318 | 2.88e-04 |
| 10910 | Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000174 | 2.86e-04 |
| 10911 | TFF2 levels | GCST90470836 | 2.86e-04 |
| 10912 | Physical activity (Total log acceleration 8am-10am) | GCST90061413 | 2.86e-04 |
| 10913 | Retinal thickness (functional principal component 6) | GCST90455726 | 2.85e-04 |
| 10914 | Nasal polyps (PheCode 471) | GCST90476019 | 2.85e-04 |
| 10915 | Inpatient record format - UK HES Inpatients (2017 format) | Summary Administration | UKBB00000365 | 2.85e-04 |
| 10916 | Age at onset of walking | GCST90651078 | 2.84e-04 |
| 10917 | AmygNuclei lh volume Medial-nucleus | GCST90002653 | 2.83e-04 |
| 10918 | FBP1 levels | GCST90469195 | 2.82e-04 |
| 10919 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T429 | ECGA000429 | 2.82e-04 |
| 10920 | BCAM/LGALS4 ratio | GCST90313473 | 2.81e-04 |
| 10921 | BTN2A1/CSF1 ratio | GCST90313541 | 2.81e-04 |
| 10922 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T440 | ECGU000440 | 2.80e-04 |
| 10923 | Never eat sugar vs no sugar restrictions (UKB data field 6144) | GCST90132934 | 2.80e-04 |
| 10924 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T448 | ECGA000448 | 2.80e-04 |
| 10925 | DTI TBSS FA Posterior thalamic radiation L | GCST90384409 | 2.79e-04 |
| 10926 | SSC-A on plasmacytoid Dendritic Cell | GCST90002072 | 2.78e-04 |
| 10927 | BMPER levels | GCST90468455 | 2.78e-04 |
| 10928 | MMP7 levels | GCST90469921 | 2.76e-04 |
| 10929 | Chronic obstructive pulmonary disease x ever smoker interaction (main effect) | GCST90016586 | 2.75e-04 |
| 10930 | KLRD1 levels | GCST90469711 | 2.75e-04 |
| 10931 | N-acetyltaurine levels | GCST90199967 | 2.74e-04 |
| 10932 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T285 | ECGU000285 | 2.74e-04 |
| 10933 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T71 | ECGA000071 | 2.74e-04 |
| 10934 | Medication use (diuretics) | GCST90018765 | 2.73e-04 |
| 10935 | FOLH1 levels | GCST90469258 | 2.72e-04 |
| 10936 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T100 | ECGA000100 | 2.72e-04 |
| 10937 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T15 | ECGU000015 | 2.71e-04 |
| 10938 | Takes medication for migraine headaches? | GCST90475547 | 2.70e-04 |
| 10939 | OGFR levels | GCST90470118 | 2.70e-04 |
| 10940 | Number of sexual partners in opposite-sex sexual behavior | GCST90026482 | 2.69e-04 |
| 10941 | BA-exvivo lh thickness V2 | GCST90003523 | 2.69e-04 |
| 10942 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T480 | ECGA000480 | 2.68e-04 |
| 10943 | Eosinophill count (UKB data field 30150) | GCST90468068 | 2.68e-04 |
| 10944 | BCR levels | GCST90468436 | 2.66e-04 |
| 10945 | DBNL/HEXIM1 ratio | GCST90314417 | 2.66e-04 |
| 10946 | BAX/MAX ratio | GCST90313466 | 2.65e-04 |
| 10947 | EDAR/F2R ratio | GCST90314577 | 2.65e-04 |
| 10948 | Asthma-related infections | FING00000118 | 2.65e-04 |
| 10949 | Subclinical hypothyroidism in pregnancy | GCST90435197 | 2.63e-04 |
| 10950 | Other non-epithelial cancer of skin (PheCode 172.2) | GCST90475580 | 2.63e-04 |
| 10951 | Actinic keratosis (PheCode 702.1) | GCST90476204 | 2.62e-04 |
| 10952 | CD27/DLL1 ratio | GCST90313771 | 2.62e-04 |
| 10953 | Medication use (adrenergics, inhalants) | GCST90018779 | 2.60e-04 |
| 10954 | Diacylglycerol_36:5_[M+H-H2O]1+ levels | GCST90060187 | 2.60e-04 |
| 10955 | Macular degeneration, dry (PheCode 362.21) | GCST90475851 | 2.59e-04 |
| 10956 | Non-albumin protein levels | UKBB00000503 | 2.59e-04 |
| 10957 | Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000641 | 2.59e-04 |
| 10958 | Other non-epithelial cancer of skin | neoplasms | UKBB00000615 | 2.59e-04 |
| 10959 | DNAJB14 levels | GCST90469011 | 2.58e-04 |
| 10960 | CX3CL1/DSG2 ratio | GCST90314323 | 2.58e-04 |
| 10961 | CXCL3/CXCL5 ratio | GCST90314344 | 2.57e-04 |
| 10962 | CD300C/GOLM2 ratio | GCST90313788 | 2.56e-04 |
| 10963 | GZMA/IL12A_IL12B ratio | GCST90315009 | 2.56e-04 |
| 10964 | PRKRA levels | GCST90470331 | 2.55e-04 |
| 10965 | Comfortable retirement (confirmatory factor analysis Factor 29) | GCST90309363 | 2.53e-04 |
| 10966 | SPRR3 levels | GCST90470737 | 2.53e-04 |
| 10967 | DAPP1/SDC4 ratio | GCST90314399 | 2.52e-04 |
| 10968 | T1 CAT GM unnormalised volume | GCST90383982 | 2.51e-04 |
| 10969 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T443 | ECGA000443 | 2.51e-04 |
| 10970 | Athlete's foot (PheCode 110.12) | GCST90475563 | 2.50e-04 |
| 10971 | Biological Sibling: Coronary Artery / Coronary Heart Disease | GCST90476370 | 2.50e-04 |
| 10972 | LAT2/SDC4 ratio | GCST90315278 | 2.48e-04 |
| 10973 | Colon polyp | GCST90018607 | 2.47e-04 |
| 10974 | Horseradish liking | GCST90094783 | 2.47e-04 |
| 10975 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T101 | ECGA000101 | 2.46e-04 |
| 10976 | MLN levels | GCST90469913 | 2.46e-04 |
| 10977 | Restless legs syndrome | GCST90435387 | 2.46e-04 |
| 10978 | Arthropathies in other diseases classified elsewhere | FING00000108 | 2.45e-04 |
| 10979 | DTI TBSS MD Body of corpus callosum | GCST90384575 | 2.45e-04 |
| 10980 | Cancer (standard GWA) | GCST90267270 | 2.45e-04 |
| 10981 | GZMA/GZMB ratio | GCST90315007 | 2.43e-04 |
| 10982 | ATOX1/SPARC ratio | GCST90313375 | 2.43e-04 |
| 10983 | End-diastolic bi-ventricular shape (principal component 5) | GCST90448484 | 2.43e-04 |
| 10984 | Risk taking (standard GWA) | GCST90267298 | 2.42e-04 |
| 10985 | IDP T1 FAST ROIs R lingual gyrus | GCST90002522 | 2.40e-04 |
| 10986 | Left ventricular end systole anterior wall thickness | GCST90278512 | 2.38e-04 |
| 10987 | Nontoxic uninodular goiter (PheCode 241.1) | GCST90475640 | 2.38e-04 |
| 10988 | IDP dMRI TBSS OD External capsule L | GCST90004435 | 2.37e-04 |
| 10989 | Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144) | GCST90132931 | 2.36e-04 |
| 10990 | Stroke | GCST006906 | 2.36e-04 |
| 10991 | Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000175 | 2.35e-04 |
| 10992 | DTI autoptx L1 slf l tract | GCST90385160 | 2.34e-04 |
| 10993 | Trauma (confirmatory factor analysis Factor 9) | GCST90309343 | 2.34e-04 |
| 10994 | Lysophosphatidylcholine (24:0) [sn2] levels | GCST90024187 | 2.33e-04 |
| 10995 | Rheumatoid arthritis (PheCode 714.1) | GCST90476230 | 2.33e-04 |
| 10996 | eosinophil (fraction, minimum, inv-norm transformed) | GCST90475303 | 2.32e-04 |
| 10997 | TNFRSF11B levels | GCST90470903 | 2.32e-04 |
| 10998 | Salt added to food | Diet | UKBB00000762 | 2.32e-04 |
| 10999 | Diastolic blood pressure | GCST90472777 | 2.32e-04 |
| 11000 | Breast cancer | GCST010098 | 2.31e-04 |